Gizem Korkut
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gizem Korkut has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Ayfer Bakır
Department of Medical Microbiology, Ankara Etlik City Hospital, Ankara 06170, Türkiye
3 shared publications - Eylül Beren Tanık
Türkiye Halk Sağlığı Kurumu, Mikrobiyoloji Referans Laboratuvarları Dairesi, Ankara
2 shared publications - Muhammed Furkan Kürkçü
Department of Medical Microbiology, Ankara Etlik City Hospital, Ankara 06170, Türkiye
2 shared publications Betül Yüzügüldü
National Virology Reference Laboratory, Ministry of Health General Directorate of Public Health Ankara Türkiye
1 shared publication- Betül Yüzügüldü
Department of Microbiology, Ankara Etlik City Hospital, University of Health Sciences, Ankara 06170, Türkiye
1 shared publication - Firdevs Şahin Duran
Sağlık Bilimleri Üniversitesi Etlik Şehir Hastanesi Tıbbi Patoloji Kliniği
1 shared publication
Latest Publications
- 8 September 2025
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 190, 525-530
Prevalence of Toxoplasma gondii in patients with schizophrenia and its association with clinical symptoms
- 8 September 2025
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 190, 525-530
Prevalence of Toxoplasma gondii in patients with schizophrenia and its association with clinical symptoms
- 5 September 2025
- Published by Wiley in Journal of Medical Virology
- Vol. 97 (9) , e70593
Prevalence of Human Herpesvirus 8 Infection in Patients With Type 2 Diabetes and Blood Donors
Human herpesvirus 8 (HHV‐8) positivity rates vary across regions. The rates are higher in immunosuppressed patients. There is a potential association between HHV‐8 and type 2 diabetes. The aim of this study is to determine the prevalence of HHV‐8 infection in type 2 diabetes patients and healthy blood donors, and to investigate whether the presence of the infection could be a risk factor for type 2 diabetes. In this cross‐sectional study, 90 type 2 diabetes patients and 180 healthy blood donors were included between July and October 2024 at Ankara Etlik City Hospital. HHV‐8 IgG seroprevalence was assessed using enzyme‐linked immunosorbent assay, and HHV‐8 DNA was detected via real‐time polymerase chain reaction. HHV‐8 seropositivity was detected in 7.8% of type 2 diabetes patients and 6.1% of blood donors, with no statistically significant difference between the two groups ( p = 0.605). The odds ratio of HHV‐8 infection in the type 2 diabetes group compared to the blood donor group was 1.29 (95% CI: 0.48–3.46, p = 0.605), indicating no significant association between HHV‐8 and diabetes. No HHV‐8 DNA was detected in any participant. Seropositivity was most prevalent in the 51–65 age group among diabetic patients and in the 31–40 age group among blood donors. There was no significant correlation between HHV‐8 seropositivity and diabetes duration, sex, or age. HHV‐8 seroprevalence was similar in type 2 diabetes patients and blood donors, suggesting no significant association between HHV‐8 infection and diabetes. However, due to regional differences, methodological variations, and limited sample size, further large‐scale, multicenter studies with long‐term follow‐up are necessary to clarify the potential role of HHV‐8 in type 2 diabetes pathogenesis.
- 5 September 2025
- Published by Wiley in Journal of Medical Virology
- Vol. 97 (9) , e70593
Prevalence of Human Herpesvirus 8 Infection in Patients With Type 2 Diabetes and Blood Donors
Human herpesvirus 8 (HHV‐8) positivity rates vary across regions. The rates are higher in immunosuppressed patients. There is a potential association between HHV‐8 and type 2 diabetes. The aim of this study is to determine the prevalence of HHV‐8 infection in type 2 diabetes patients and healthy blood donors, and to investigate whether the presence of the infection could be a risk factor for type 2 diabetes. In this cross‐sectional study, 90 type 2 diabetes patients and 180 healthy blood donors were included between July and October 2024 at Ankara Etlik City Hospital. HHV‐8 IgG seroprevalence was assessed using enzyme‐linked immunosorbent assay, and HHV‐8 DNA was detected via real‐time polymerase chain reaction. HHV‐8 seropositivity was detected in 7.8% of type 2 diabetes patients and 6.1% of blood donors, with no statistically significant difference between the two groups ( p = 0.605). The odds ratio of HHV‐8 infection in the type 2 diabetes group compared to the blood donor group was 1.29 (95% CI: 0.48–3.46, p = 0.605), indicating no significant association between HHV‐8 and diabetes. No HHV‐8 DNA was detected in any participant. Seropositivity was most prevalent in the 51–65 age group among diabetic patients and in the 31–40 age group among blood donors. There was no significant correlation between HHV‐8 seropositivity and diabetes duration, sex, or age. HHV‐8 seroprevalence was similar in type 2 diabetes patients and blood donors, suggesting no significant association between HHV‐8 infection and diabetes. However, due to regional differences, methodological variations, and limited sample size, further large‐scale, multicenter studies with long‐term follow‐up are necessary to clarify the potential role of HHV‐8 in type 2 diabetes pathogenesis.
- Open Access
- 17 July 2025
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 10 (7) , 200
Investigation of the Prevalence of High-Risk Human Papillomavirus, Human Herpesvirus-8, and Herpes Simplex Virus-2 in Cervical Biopsy Samples Using the Real-Time PCR Method
Persistent high-risk human papillomavirus (HR-HPV) infection is closely associated with the development of cervical intraepithelial neoplasia (CIN) and cervical cancer. In recent years, the potential impact of viral co-infections on this process has also been investigated. This study investigated the presence of HR-HPV, HSV-1/2, and HHV-8 DNA in formalin-fixed paraffin-embedded (FFPE) cervical biopsy samples, as well as their association with lesion severity. A total of 276 FFPE cervical tissue samples were evaluated. Viral DNA was detected by real-time PCR. The samples were histopathologically classified as normal/non-dysplastic, low-grade (LSIL), and high-grade (HSIL) lesions. HR-HPV DNA was detected in 112 samples (40.6%), with the highest prevalence observed in the 30–39 age group (51.2%). Among the HPV-positive cases, 46.5% (52/112) had single-type infections, 32.1% (36/112) had multiple-type infections, and 21.4% (24/112) were untypable. Together, these categories accounted for all HPV-positive samples. The most common genotype was HPV-16 (16.7%). HHV-8 and HSV-2 DNA were not detected. HSV-1 DNA was detected in only three non-dysplastic, HPV-negative cervical samples. In conclusion, HR-HPV DNA was detected in 40.6% of cervical biopsy samples and showed a significant association with increasing histological severity, highlighting its critical role in the progression of cervical lesions. Although the absence of HHV-8 and HSV-2 suggests a limited contribution of these viruses to cervical disease, the use of a single real-time PCR assay limits the ability to draw generalized conclusions regarding their clinical relevance. Further large-scale, multicenter studies employing both tissue-based and serological approaches are needed to validate these findings and to better understand the dynamics of viral co-infections in cervical disease.
- 17 July 2025
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 10 (7) , 200
Open AccessInvestigation of the Prevalence of High-Risk Human Papillomavirus, Human Herpesvirus-8, and Herpes Simplex Virus-2 in Cervical Biopsy Samples Using the Real-Time PCR Method
Persistent high-risk human papillomavirus (HR-HPV) infection is closely associated with the development of cervical intraepithelial neoplasia (CIN) and cervical cancer. In recent years, the potential impact of viral co-infections on this process has also been investigated. This study investigated the presence of HR-HPV, HSV-1/2, and HHV-8 DNA in formalin-fixed paraffin-embedded (FFPE) cervical biopsy samples, as well as their association with lesion severity. A total of 276 FFPE cervical tissue samples were evaluated. Viral DNA was detected by real-time PCR. The samples were histopathologically classified as normal/non-dysplastic, low-grade (LSIL), and high-grade (HSIL) lesions. HR-HPV DNA was detected in 112 samples (40.6%), with the highest prevalence observed in the 30–39 age group (51.2%). Among the HPV-positive cases, 46.5% (52/112) had single-type infections, 32.1% (36/112) had multiple-type infections, and 21.4% (24/112) were untypable. Together, these categories accounted for all HPV-positive samples. The most common genotype was HPV-16 (16.7%). HHV-8 and HSV-2 DNA were not detected. HSV-1 DNA was detected in only three non-dysplastic, HPV-negative cervical samples. In conclusion, HR-HPV DNA was detected in 40.6% of cervical biopsy samples and showed a significant association with increasing histological severity, highlighting its critical role in the progression of cervical lesions. Although the absence of HHV-8 and HSV-2 suggests a limited contribution of these viruses to cervical disease, the use of a single real-time PCR assay limits the ability to draw generalized conclusions regarding their clinical relevance. Further large-scale, multicenter studies employing both tissue-based and serological approaches are needed to validate these findings and to better understand the dynamics of viral co-infections in cervical disease.